Practical Geriatrics ›› 2021, Vol. 35 ›› Issue (8): 789-794.doi: 10.3969/j.issn.1003-9198.2021.08.001
Received:2021-06-15
Online:2021-08-20
Published:2021-08-30
CLC Number:
| [1] BAILLIEUL S, REVOL B, JULLIAN-DESAYES L, et al. Diagnosis and management of central sleep opnea syndrom[J]. Expert Revpir Med, 2019, 13(6): 545-557. [2] MARTIN R R, BATES M D. Management of atrial fibrillation and concomitant coronary artery disease[J]. Continuing Cardiol Education, 2017, 3(2) :47-55. [3] DAI H, ZHANG Q, ABU M A, et al. Global, regional, and national prevalence, incidence, mortality, and risk factors for atrial fibrillation, 1990—2017: results from the Global Burden of Disease Study 2017[J]. Eur Heart J Qual Care Clin Outcomes, 2020. DOI: 10.1093/ehjqcco/qcaa061. [4] GO A S, HYLEK E M, PHILLIPS K A, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study[J]. JAMA, 2001, 285(18): 2370-2375. [5] ZAKERI R, BORLAUG B A, MCNULTY S, et al. Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study[J]. Circ Heart Fail, 2013,7(1): 123-30. [6] CHASE D, KUMAR V, HOODA A. Dual-site right ventricular and left ventricular pacing in a patient with left ventricular systolic dysfunction and atrial fibrillation using a standard CRT-D device[J]. J Saudi Heart Assoc, 2013, 25(3): 213-218. [7] JONES J D, KHAND A U, DOUGLAS H, et al. The intersection of atrial fibrillation and heart failure in a hospitalized population[J]. Acta Cardiol, 2013, 68(4): 395-402. [8] HARMON E K, PATRICK S, SAMI I, et al. Atrial fibrillation is associated with central sleep apnea in clinic patients undergoing diagnostic polysomnography[J]. J Arrhythm, 2020, 36(6): 991-996. [9] SANCHEZ A M, ROBIN G, LOZIER M R,et al. Central sleep apnea and atrial fibrillation: a review on pathophysiological mechanisms and therapeutic implications[J]. Int J Cardiol Heart Vasc, 2020, 30: 100527. [10] 苏士成,丁宁,张希龙,等. 心衰合并心房颤动患者睡眠呼吸暂停综合征的发生情况及临床特征[J].中华医学杂志,2015,95(40): 3278-3280. [11] ALSHOAIBI N. Outcome of cardiac monitor during sleep study for screening of subclinical atrial fibrillation[J]. Cureus, 2020, 12(7): e8987. [12] COSTANZO M R, KHAYAT R, PONIKOWSKI P, et al. Mechanisms and clinical consequences of untreated central sleep apnea in heart failure[J]. J Am Coll Cardiol, 2015, 65(1): 72-84. [13] HERNANDEZ A V, JEON A, DENEGRI-GALVAN J, et al. Use of adaptive servo ventilation therapy as treatment of sleep-disordered breathing and heart failure: a systematic review and meta-analysis[J]. Sleep Breath, 2020, 24(1): 49-63. [14] KHAYAT R N, JAVAHERI S, PORTER K, et al. In-hospital management of sleep apnea during heart failure hospitalization: a randomized controlled trial[J]. J Card Fail, 2020, 26(8): 705-712. [15] FLORAS J S. Sleep apnea and cardiovascular disease: an enigmatic risk factor[J]. Circ Res, 2018, 122(12): 1741-1764. [16] ANZAI T, GRANDINETTI A, KATZ A R, et al. Association between central sleep apnea and atrial fibrillation/flutter in Japanese-American men: The Kuakini Honolulu heart program (HHP) and Honolulu-Asia aging study (HAAS)[J]. J Electrocardiol, 2020, 61:10-17. [17] VAHDATPOUR C A, LUEBBERT J J, PALEVSKY H I,et al. Atrial arrhythmias in chronic lung disease-associated pulmonary hypertension [J]. Pulm Circ, 2020, 10(1): 2045894020910685. [18] SANCHEZ A M, GERMANY R, LOZIER M R, et al. Central sleep apnea and atrial fibrillation: a review on pathophysiological mechanisms and therapeutic implications[J]. Int J Cardio Heart Vasc, 2020, 30:100527. [19] BABAPOOR-FARROKHRAN S, GILL D, ALZUBI J, et al. Atrial fibrillation: the role of hypoxia-inducible factor-1-regulated cytokines[J]. Mol Cell Biochem, 2021, 476(6): 2283-2293. [20] ZHANG K, MA Z W, SONG C, et al. Role of ion channels in chronic intermittent hypoxia-induced atrial remodeling in rats [J]. Life Sci, 2020, 254:117797. [21] TUNG P, LEVITZKY Y S, WANG R, et al. Obstructive and central sleep apnea and the risk of incident atrial fibrillation in a community cohort of men and women[J]. J Am Heart Assoc, 2017, 6(7): e004500. [22] KWON Y, LOGAN J, PUSALAVIDYASAGAR S, et al. Sleep apnea and heart[J]. Sleep Medicine Research, 2019, 10(2): 67-74. [23] SADEGHI Y, SEDAGHAT M, MAJEDI M A, et al. Comparative evaluation of therapeutic approaches to central sleep apnea [J]. Adv Biomed Res, 2019, 8: 13. [24] KUETTING D L R, FEISST A, SPRINKART A M, et al. Effects of a 24-hr-shift-related short-term sleep deprivation on cardiac function: a cardiac magnetic resonance-based study [J]. J Sleep Res, 2019, 28(3): e12665. [25] SMITH J R, SUTTERFIELD S L, BAUMFALK D R, et al. Left ventricular strain rate is reduced during voluntary apnea in healthy humans [J]. J Appl Physiol, 2017, 123(6): 1730-1737. [26] ZHAO L, LI S N, ZHANG C, et al. Cardiovascular magnetic resonance-determined left ventricular myocardium impairment is associated with C-reactive protein and ST2 in patients with paroxysmal atrial fibrillation [J]. J Cardiovasc Magn Reson, 2021, 23(1): 30. [27] LIU L S, CHEN Y B, SHU J, et al. Identification of microRNAs enriched in exosomes in human pericardial fluid of patients with atrial fibrillation based on bioinformatic analysis [J]. J Thorac Dis, 2020, 12(10): 5617-5627. [28] JAVAHERI S, BARBE F, CAMPOS-RODRIGUEZ F, et al. Sleep apnea: types, mechanisms, and clinical cardiovascular consequences[J]. J Am Coll Cardiol, 2017,69(7): 841-858. [29] 田彦明.呼吸-交感神经偶联在高血压发病中的作用及其机制研究[D]. 石家庄: 河北医科大学, 2017. [30] 喻淑慧,李园园,胡克.去肾交感神经术治疗顽固性高血压合并阻塞性睡眠呼吸暂停的研究进展[J]. 中国呼吸与危重监护杂志,2015,14(3): 317-320. [31] YANG Y X, NING Y, WEN W W, et al. CPAP is associated with decreased risk of AF recurrence in patients with OSA, especially those younger and slimmer: a meta-analysis [J]. J Interv Card Electrophysiol, 2020, 58(3): 369-379. [32] KONECNY T, BRADY P A, PARK J Y, et al. Usefulness of heart rate control in atrial fibrillation patients with obstructive sleep apnea [J]. Am J Cardiol, 2018, 122(9): 1482-1488. [33] TAMISIER R, BOCQUILLON V, TREPTOW E, et al. Prevalence and factors contributing to daytime and nocturnal hypoxemia in chronic heart failure patients [J]. Respiration, 2019, 97(3): 213-222. [34] PRIGENT A, SERANDOUR A L, LURAINE R, et al. Interrelated atrial fibrillation and leaks triggering and maintaining central sleep apnoea and periodic breathing in a CPAP-treated patient [J]. Respirol Case Rep, 2020, 8(8): e00666. [35] GOUDIS C A, KETIKOGLOU D G.Obstructive sleep and atrial fifibrillation: pathophysiological mechanisms and therapeutic implications [J]. Int J Cardiol, 2017, 230: 293-300. [36] AURORA R N, CHOWDHURI S, RAMAR K, et al. Tracy, the treatment of central sleep apnea syndromes in adults: practice parameters with an evidence-based literature review and meta-analyses[J]. Sleep, 2012, 35 (1):17-40. [37] SCHWARZ E I, SCHERFF F, HAILE S R,et al. Effect of treatment of central sleep apnea/cheyne-stokes respiration on left ventricular ejection fraction in heart failure: a network meta-analysis [J]. J Clin Sleep Med, 2019, 15(12): 1817-1825. [38] KOLB L, ARZT M, STADLER S, et al. Adaptive servo-ventilation in patients with chronic heart failure and sleep disordered breathing: predictors of usage[J]. Sleep Breath, 2020,25(2): 1135-1145. [39] PICCINI J P, POKORNEY S D, ANSTROM K J et al. Adaptive servo-ventilation reduces atrial fifibrillation burden in patients with heart failure and sleep apnea[J]. Heart Rhythm, 2019,16(1): 91-97. [40] LATASTE B, LATASTE A, HOFMANN P, et al. Nocturnal oxygen therapy in patients with chronic heart failure and sleep apnea: a systematic review[J]. Sleep Med, 2016,17 :149-157. [41] OWIE M R, WOEHRLE H, WEGSCHEIOER K, et al. Adaptive servoventilation for central sleep apnea in systolic heart failure[J]. New Engl J Med,2015,373 (12) :1095-1105. [42] WONGBOONSIN J,THONGPRAYOON C,BATHINI T,et al. Acetazolamide therapy in patients with heart failure: a meta-analysis[J]. J Clin Med, 2019, 8(3):349. [43] JULLIAN-DESAYES I,REVOL B,CHAREYRE E,et al. Impact of concomitant medications on obstructive sleep apnoea[J]. Br J Clin Pharmacol, 2017, 83(4): 688-708. [44] JAGIELSKI D, PONIKOWSKI P, AUGOSTINI R, et al.Transvenous stimulation of the phrenic nerve for the treatment of central sleep apnea: 12 months experience with Remede System[J]. Eur J Heart Fail,2016,18 (11) :1386-1393. [45] AUGOSTINI R, STELLBRINK C, JAGIELSKI D, et al. Phrenic nerve stimulation is safe and improves sleep and qol in patients with central sleep apnea and atrial fibrillation regardless of heart failure status[J]. J Cardiac Fail, 2019, 25 (8) :S83. |
| [1] | ZHOU Yun, ZHANG Yingying, GAO Yanfen. Effect of Feilike Mixture combined with tiotropium bromide powder aerosol in elderly patients aged≥80 years old with chronic obstructive pulmonary disease [J]. Practical Geriatrics, 2024, 38(10): 1011-1015. |
| [2] | LEI Wanfeng, MA Xiuhong. Study on expression of serum IL-33/sST2 axis in elderly patients with acute exacerbation of COPD and its predictive value for prognosis [J]. Practical Geriatrics, 2024, 38(10): 1044-1048. |
| [3] | XU Jinyan, XIA Congcong, YANG Hongmei. Establishment and validation of a Nomogram to predict the risk of pulmonary infection in elderly patients with stroke [J]. Practical Geriatrics, 2024, 38(5): 452-437. |
| [4] | PENG Zetong, ZHANG Yao, LIU Bin. Analysis of the effects of anemia on death in elderly patients with community-acquired pneumonia [J]. Practical Geriatrics, 2024, 38(3): 260-264. |
| [5] | . [J]. Practical Geriatrics, 2024, 38(3): 291-292. |
| [6] | . [J]. Practical Geriatrics, 2024, 38(3): 322-324. |
| [7] | WANG Ruiping, ZHANG Ni. Correlation of carbon monoxide diffusion with exercise tolerance, dyspnea and ventilation efficiency in patients with chronic obstructive pulmonary disease [J]. Practical Geriatrics, 2024, 38(2): 141-144. |
| [8] | . [J]. Practical Geriatrics, 2024, 38(2): 176-178. |
| [9] | . [J]. Practical Geriatrics, 2024, 38(2): 203-205. |
| [10] | QIN Ke, LI Tong-lin, HUA Jun-ping, JIANG Mei-fang. Expression level and significance of serum progranulin in elderly patients with chronic obstructive pulmonary disease treated by high-flow nasal cannula oxygen therapy [J]. Practical Geriatrics, 2023, 37(12): 1215-1218. |
| [11] | . [J]. Practical Geriatrics, 2023, 37(11): 1081-1075. |
| [12] | . [J]. Practical Geriatrics, 2023, 37(11): 1086-1091. |
| [13] | WANG Xue-jing, DENG Bao-feng, LUO Chang-chun, ZHAO Yu-rong, ZHANG Ai-jun, LIU Hai-rong, ZHAO Yan-mei. Application of a remote visitation system for elderly inpatients with cancer during the novel coronavirus infection epidemic period [J]. Practical Geriatrics, 2023, 37(11): 1095-1098. |
| [14] | . [J]. Practical Geriatrics, 2023, 37(11): 1166-1169. |
| [15] | WANG Shi-fu, OU Zong-xing, FU Sha-sha. Association of vasoactive intestinal peptides with hypercoagulability, hypoxemia and vascular endothelial function in elderly patients with chronic obstructive pulmonary disease complicated with pulmonary hypertension [J]. Practical Geriatrics, 2023, 37(9): 907-910. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
|
